The Home of the Life Sciences Industry

Explore Latest News

CKD Drug Hit Phase III Endpoints Yet Rejected by FDA

Shares of Ardelyx, Inc. have fallen nearly 13% in premarket trading after the U.S. FDA rejected the company's chronic kidney disease drug, tenapanor.

Annovis Bio’s AD/PD Therapy Reduces Cytotoxic Cascade in Phase IIa Trials

Annovis Bio’s therapy for Alzheimer’s disease is fast-acting and has the potential for Alzheimer’s patients to significantly improve cognition and motor function, according to data presented at the Alzheimer’s Association International Conference® 2021 (AAIC®), held July 26th through 30th.  

Get personalized job alerts

Create a job alert and receive custom job recommendations straight to your inbox.


Post jobs on BioSpace and start building your talent pipeline today. Click the button to access our easy eCommerce site, which lets you purchase and post jobs in just a few clicks.

Post Jobs Now